Ocular Hypotony Treatment & Management

  • Author: Sheila P Sanders, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Feb 9, 2010
 

Medical Care

  • Hypotony is best managed by correcting the underlying problem. As a temporizing measure, the anterior chamber may be inflated with viscoelastic or a pars plana injection of viscoelastic or gas may be administered.
    • No clinically useful medications are available that raise intraocular pressure (IOP) as a primary action, although a study using topical ibopamine resulted in a significant reduction of hypotony.[3]
    • Steroids may elevate IOP with prolonged use in individuals who are prone to a steroid response and may improve aqueous humor production by decreasing ciliary body inflammation.
    • Increased fluid intake may slightly increase aqueous humor production.
  • With inflammatory conditions or with recent surgery or trauma, topical prednisolone acetate is the mainstay of therapy. Additional therapy, such as topical or systemic nonsteroidal anti-inflammatory agents (NSAIDs), systemic, sub-Tenon, or intravitreal steroids, or other systemic medications (eg, methotrexate, cyclosporin), may be appropriate. Because steroids can slow wound healing, use should be moderated in the case of wound leak or overfiltering bleb.
  • Aqueous humor suppressants can decrease flow through an overfiltering bleb or a wound leak long enough for healing to occur but can potentially worsen hypotony. The use of acetazolamide to accelerate absorption of suprachoroidal fluid is controversial.
  • Atropine and other cycloplegics deepen the anterior chamber, lessen iris-corneal touch, and restore normal anatomy of the lens-iris diaphragm and ciliary body.
    • Pupillary dilation prevents a permanently small fixed pupil if synechiae form.
    • Unfortunately, atropine also increases the uveoscleral outflow and can contribute to increased choroidal effusion, although its benefits usually outweigh its risks.
Next

Surgical Care

  • Wound leaks
    • Small wound leaks with a well-formed anterior chamber can be conservatively managed with patching or a large diameter bandage contact lens with prophylactic topical antibiotics.
    • Cyanoacrylate may be applied over a focal leak with a contact lens placed over the glue for comfort and stability.
    • Larger wound leaks that cause clinically significant hypotony or seem unlikely to spontaneously resolve are best managed with surgical revision.
  • Cyclodialysis cleft[4]
    • Separation of the ciliary body from the scleral spur creates a large direct channel for uveoscleral outflow. Detachment of the ciliary body may, but does not necessarily, reduce aqueous humor production.
    • Cleft size does not bear directly on the degree of hypotony. The cleft may have been inadvertently created during ocular surgery or following trauma or intentionally created during a glaucoma operation.
    • A cyclodialysis cleft may be identified gonioscopically, by anterior segment imaging, or during exploratory surgery. Gonioscopy can be difficult on a soft globe.
    • Treatment options include argon laser photocoagulation, cryotherapy, external diathermy, and ciliary body suturing.
    • When the cleft closes, a dramatic rise in IOP can occur.
    • Clefts can spontaneously close.
    • Miotics should be avoided to prevent recurrence of cleft opening. After cleft closure, long-term cycloplegia may be indicated.
  • Retinal detachment
    • Rhegmatogenous retinal detachment is usually associated with mild hypotony. Occasionally, with large detachments, profound hypotony may develop.
    • The mechanism is believed to be the egress of aqueous humor through the vitreous, the retinal hole, and across the retinal pigment epithelium (RPE). Concurrent iridocyclitis may also reduce aqueous humor production.
    • Hypotony may slowly resolve following repair of the detachment because of lingering inflammation, or it may quickly reverse if, for example, a scleral buckle or silicone oil is used.
  • Overfiltering bleb or tube shunt, or posttraumatic hypotony
    • Acute
      • Mild transient hypotony following glaucoma surgery is common and usually well tolerated.
      • Observe and treat with liberal anti-inflammatory agents, cycloplegic agents, and reformation of the anterior chamber with viscoelastic, if needed. Viscoelastic injections may be repeatedly given.
      • Continue topical antibiotics for several days beyond the last chamber reformation procedure.
      • Anterior chamber shallowing becomes clinically significant if corneal-iris touch or corneal-lens touch results in development of synechiae or corneal decompensation.
      • Consider draining large choroidal effusions if no sign of improvement is present after several (7-14) days of medical and/or chamber reformation management, especially if retinal apposition is noted, the anterior chamber is markedly shallow, or the patient is at higher risk for hemorrhage. Hemorrhage risk factors include advanced age, history of glaucoma, history of vascular disease, and anticoagulated status. Even large choroidal effusions can resolve with conservative management, avoiding the need for further surgery.
    • Chronic
      • Surgical wound revision with resuturing of the scleral flap and/or conjunctival advancement or autograft is the procedure of choice for incompetent or overfiltering trabeculectomy. Blood patch, laser application, cautery, cryotherapy, and trichloroacetic acid may work in some instances but are less effective.
      • Conjunctival flaps alone can work well for diffusely incompetent blebs due to tissue thinning and avascularity.
      • Focal leaks may be treated with cyanoacrylate and a bandage lens, or temporary patching.
      • Eroded tube shunts can be particularly challenging to stabilize, and numerous graft alternatives, including cornea, dermis, and fascia lata, have been used with some success.[5] Care must be taken to remove any epithelial tissue that has grown in through the erosion. The position of the tube may need modification. In most cases of recurrent tube erosion, the device should be removed.
    • Uveitis
      • Anti-inflammatory agents are the mainstay of treatment. Peribulbar or intravitreal steroid injections have been used with some success, even in prephthisical eyes. Surgical removal of a cyclitic membrane may release tractional detachment of the ciliary body.
      • Vitrectomy and placement of silicone oil may be useful in refractory cases.
Previous
Next

Consultations

  • Practitioners who have limited experience with hypotony should consider consultation with a glaucoma or retina subspecialist.
  • Consultation with a rheumatologist or internal medicine specialist is appropriate for difficult uveitic cases and for patients with uncontrolled systemic disorders.
Previous
Next

Diet

  • Patients at risk for hypotony should maintain good hydration.
Previous
Next

Activity

  • The patient should avoid lifting, bending, and strenuous activity. Sudden movement or straining could cause a vessel, which is already stretched in the suprachoroidal space, to bleed and create a suprachoroidal hemorrhage.
  • The patient should avoid any direct pressure on the eye that could cause further decompression. An eye shield, especially during sleep, is advisable.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Sheila P Sanders, MD  Associate Professor, Director of Glaucoma Service, Department of Ophthalmology, University of Kentucky College of Medicine

Sheila P Sanders, MD is a member of the following medical societies: American Academy of Ophthalmology and American Glaucoma Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Bradford Shingleton, MD  Assistant Clinical Professor of Ophthalmology, Harvard Medical School; Consulting Staff, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary

Bradford Shingleton, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

J James Rowsey, MD  Former Director of Corneal Services, St Luke's Cataract and Laser Institute, Florida

J James Rowsey, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for the Advancement of Science, American Medical Association, Association for Research in Vision and Ophthalmology, Florida Medical Association, Pan-American Association of Ophthalmology, Sigma Xi, and Southern Medical Association

Disclosure: Nothing to disclose.

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Fannin LA, Schiffman JC, Budenz DL. Risk factors for hypotony maculopathy. Ophthalmology. Jun 2003;110(6):1185-91. [Medline].

  2. Hammer ME, Grizzard WS. Endoscopy for evaluation and treatment of the ciliary body in hypotony. Retina. Feb 2003;23(1):30-6. [Medline].

  3. Ugahary LC, Ganteris E, Veckeneer M, Cohen AC, Jansen J, Mulder PG, et al. Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. Am J Ophthalmol. Mar 2006;141(3):571-3. [Medline].

  4. Aminlari A, Callahan CE. Medical, laser, and surgical management of inadvertent cyclodialysis cleft with hypotony. Arch Ophthalmol. Mar 2004;122(3):399-404. [Medline].

  5. Sarkisian SR Jr. Tube shunt complications and their prevention. Curr Opin Ophthalmol. Mar 2009;20(2):126-30. [Medline].

  6. Budenz DL, Chen PP, Weaver YK. Conjunctival advancement for late-onset filtering bleb leaks: indications and outcomes. Arch Ophthalmol. Aug 1999;117(8):1014-9. [Medline].

  7. Fine HF, Biscette O, Chang S, Schiff WM. Ocular Hypotony: A Review. Comprehensive Ophthalmology Update. Jan-Feb 2007;8:29-37.

  8. Haynes WL, Alward WL. Control of intraocular pressure after trabeculectomy. Surv Ophthalmol. Jan-Feb 1999;43(4):345-55. [Medline].

  9. Hsu J, Chen E, Gupta O, Fineman MS, Garg SJ, Regillo CD. Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes. Retina. Jul-Aug 2008;28(7):937-40. [Medline].

  10. Kunimoto DY, Kenitkar KD, Makar M. Hypotony. In: The Will's Eye Manual. Lippincott, Williams, & Wilkins; 2004:440-442.

  11. Migdal C, Hitchings R. Morbidity following prolonged postoperative hypotony after trabeculectomy. Ophthalmic Surg. Dec 1988;19(12):865-7. [Medline].

  12. Nicolela MT, Carrillo MM, Yan DB, Rafuse PE. Relationship between central corneal thickness and hypotony maculopathy after trabeculectomy. Ophthalmology. Jul 2007;114(7):1266-71. [Medline].

  13. O'Connell SR, Majji AB, Humayun MS, de Juan E Jr. The surgical management of hypotony. Ophthalmology. Feb 2000;107(2):318-23. [Medline].

  14. Pederson J. Ocular hypotony. In: Duane's Clinical Ophthalmology. Vol 3. 1993.

  15. Ritch R, Shields MB, Krupin T. Ocular hypotony. In: The Glaucomas. Vol 3. 1996:385-395.

  16. Roters S, Szurman P, Engels BF, Bartz-Schmidt KU, Krieglstein GK. Ultrasound biomicroscopy in chronic ocular hypotony: its impact on diagnosis and management. Retina. Oct 2002;22(5):581-8. [Medline].

  17. Schubert HD. Postsurgical hypotony: relationship to fistulization, inflammation, chorioretinal lesions, and the vitreous. Surv Ophthalmol. Sep-Oct 1996;41(2):97-125. [Medline].

  18. Suner IJ, Greenfield DS, Miller MP, Nicolela MT, Palmberg PF. Hypotony maculopathy after filtering surgery with mitomycin C. Incidence and treatment. Ophthalmology. Feb 1997;104(2):207-14; discussion 214-5. [Medline].

  19. Walker SD, Brubaker RF, Nagataki S. Hypotony and aqueous humor dynamics in myotonic dystrophy. Invest Ophthalmol Vis Sci. Jun 1982;22(6):744-51. [Medline].

Previous
Next
 
Seidel-positive wound leak around a conjunctival suture.
Conjunctival advancement flap sewn over a diffusely incompetent bleb.
Eroded tube shunt in a patient with rheumatoid arthritis.
Flat anterior chamber with iris-corneal touch following a phacotrabeculectomy.
Autologous blood injected into an overfiltering bleb to create a blood patch.
B-scan ultrasound of choroidal effusions before and after surgical drainage.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.